-
-
-
-
-
-
-
AbbVie shares fall on earnings miss and weak guidance
-
-
-
-
-
-
-
AbbVie to Host Second-Quarter 2026 Earnings Conference Call
-
-
-
-
-
-
-
AbbVie Reports First-Quarter 2026 Financial Results
-
-
-
-
-
-
-
AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial Results
-
-
-
-
-
-
-
AbbVie reports $1.3 billion Q4 expense from acquired research deals
-
-
-
-
-
-
-
AbbVie Reports Third-Quarter 2025 Financial Results
-
-
-
-
-
-
-
Buy this U.S. large-cap biopharma stock: JPMorgan
-
1,220,103 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

